Welcome to Urology Group of New Mexico - Vasectomy and Urology Experts
The Urology Group of New Mexico is dedicated to serving the urological needs of adults and children in the Albuquerque, NM, area. Our urologist, Dr. Frederick Snoy, is committed to providing quality urological care in a patient-friendly setting. Dr. Snoy has performed over 2,000 vasectomies making UGNM a premier vasectomy clinic. We offer vasectomy services using the modern “no scalpel” technique.
Experience has taught our practice to treat each patient as a partner in his or her medical care. Because some urological conditions are accompanied by discomfort or embarrassment, we emphasize sensitivity and discretion with all patients concerns.
Dr. Snoy is pleased to offer a variety of payment options including cash, credit card, cashier’s check and several flexible financing choices (including interest free) through CareCredit. Click the Care Credit logo to learn more or to apply.
|AccumetRx, a division of Urology Group of New Mexico will be participating in a new clinical trial. For more information about the study, contact David Waid, 505-872-4091 ext. 118, firstname.lastname@example.org.|
Study: Efficacy Study of Auriclosene Irrigation Solution on Urinary Catheter Patency
Sponsor: NovaBay Pharmaceuticals, Inc.
Long-term indwelling urinary catheters are associated with chronic recurrent urinary tract infections and blockage caused by crystalline biofilm accumulation (encrustation) of the catheter surfaces. When the urine and catheter are colonized by urease-producing bacteria such as Proteus mirabilis, encrustation of the catheter is likely to occur.
The use of a catheter irrigation solution that can prevent biofilm formation and encrustation leading to blockage may keep the catheter patent longer, resulting in fewer catheter changes, potentially lower incidence of UTIs and better patient quality of life.
Auriclosene is a non-antibiotic, fast-acting, broad-spectrum antimicrobial, which exhibits potential for the rapid decolonization of a range of urologic pathogens, including the urease-producing Proteus mirabilis.
Subjects will be randomized to either Auriclosene Irrigation Solution or Auriclosene Vehicle solution.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
|Official Title:||A Multicenter, Randomized, Double-Blind, Efficacy Study of Auriclosene Irrigation Solution on Indwelling Urinary Catheter Patency|
- Subject requiring an indwelling urinary catheter with a history of catheter blockage and/or encrustation
- Screening within 30 days of randomization
- Exclusion Criteria:
- Systemic antibiotic use within 14 days of first treatment
- Investigational drug or device within 30 days if enrollment
- Current infection requiring treatment with systemic antibiotics
- Pregnant or lactating female
|AccumetRx division of Urology Group of New Mexico|
|Albuquerque, New Mexico, United States, 87109|
|Contact: David Waid 505-872-4091 ext 118 email@example.com|